Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma

NCT01078142 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma
Mantle Cell Lymphoma

Interventions

DRUG: Temsirolimus, Rituximab, Bendamustin

Sponsor

Georg Hess, MD

Collaborators

[object Object]
[object Object]